CSL Annual Report 2024

Businesses CSL Behring discovers, develops and delivers innovative therapies for people living with a range of rare and serious health conditions. CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Vifor is a global partner of choice for pharmaceuticals and innovative, leading therapies in iron deficiency and nephrology. Find out more on page 16 Find out more on page 17 Find out more on page 18 Operating in 40+ countries around the world 3

RkJQdWJsaXNoZXIy MjE2NDg3